1 and cyclic voltammograms recorded at 300 V/s
were repeated at 0.1-s intervals.
2 After surgery, measurements
were repeated at 1, 2, and 12 months.
3 ed tissue (KT; 2.4 +/- 0.3 mm); measurements
were repeated at 1, 2, and 4 weeks and 3 and 6 months po
4 Clinical measurements
were repeated at 1, 3, and 6 months after surgery.
5 When the trains
were repeated at 1-10 s intervals, augmentation markedly
6 ence of up to 3 electrical shocks and delays
were repeated at 1-minute intervals until the animals we
7 0 mg orally twice daily continuously; cycles
were repeated at ~
1-month intervals.
8 Microbial samples
were repeated at 10 months post-baseline, and ligatures
9 plied during each experimental condition and
were repeated at 10- to 15-min intervals for 90 min afte
10 SD-OCT
was repeated at 12 and 24 months in 6 and 4 eyes respect
11 Washout of hypotensive medications
was repeated at 12 and 24 months.
12 CMR
was repeated at 12 months.
13 Clinical measurements
were repeated at 12 months.
14 Biopsies
were repeated at 12 wk and sputa at 8 and 13 wk.
15 imab, 5 mg/kg of ideal body weight; infusion
was repeated at 2 and 6 weeks.
16 PBBD procedures
were repeated at 2- to 14-day intervals until cholangiog
17 evaluated at baseline and HVPG measurements
were repeated at 2-4 weeks to determine chronic response
18 microg/kg (V + E); boluses (L, V, or V + E)
were repeated at 2.5 and 5 minutes for a rate-pressure p
19 The ion generation and extraction cycle
is repeated at 20 Hz, the maximum operating frequency of
20 endo IL-2, interferon alfa-2b, and tamoxifen
was repeated at 21-day intervals.
21 Treatment cycles
were repeated at 21-day intervals for a maximum of four
22 All assessments
were repeated at 24 weeks to test the durability of the
23 Vital signs
were repeated at 25 or 49 hours post-cecal ligation and
24 The urea breath test
was repeated at 28 days.
25 Chip placement
was repeated at 3 and/or 6 months if PD remained > or =
26 Of the 12 patients who underwent TMLR, DSE
was repeated at 3 months postoperatively in 11 patients
27 Cardiac magnetic resonance imaging
was repeated at 3 months.
28 clinical evaluations and plasma cell studies
were repeated at 3 and 12 months.
29 Clinical measurements and sampling
were repeated at 3 and 6 months.
30 Evaluations
were repeated at 3 months and 1 year after surgery.
31 All studies
were repeated at 3 months and 12 months after kidney don
32 tide (BNP) and the cardiological examination
were repeated at 3, 6, and 12 months.
33 m electrocardiograms and fasting blood draws
were repeated at 3-year intervals from 1993 to 2004.
34 odynamic and electrophysiological recordings
were repeated at 30-minute intervals for the next 4 hour
35 eatment was given using an infusion pump and
was repeated at 4- to 12-wk intervals (mean number of tr
36 Treatment
was repeated at 4-week intervals for a maximum of eight
37 Courses
were repeated at 4 and 8 weeks, and every 5 weeks therea
38 Studies
were repeated at 4-year intervals to quantify OSA.
39 The simulation
was repeated at 413 K with an applied electric field and
40 SPECT
was repeated at 43+/-26 days after therapy was optimized
41 Clinical and radiographic recordings
were repeated at 5 and 10 months post-baseline.
42 ymptoms suggestive of stenosis developed and
was repeated at 6 and 12 months if any pulmonary vein na
43 RNA
was repeated at 6 months and 6.5 days after withdrawal o
44 Language assessment
was repeated at 6 months.
45 Endoscopy
was repeated at 6, 12, and 24 weeks.
46 Spirometry
was repeated at 6-mo intervals and individual 5-yr FEV1
47 Mode switching
was repeated at 6-month intervals thereafter.
48 ission computed tomography scans and ratings
were repeated at 6 weeks.
49 esting, physical examination, and interviews
were repeated at 6, 12, and 24 month follow-up visits.
50 Gait evaluations
were repeated at 6, 12, and 24 weeks.
51 phs and soft tissue presurgical measurements
were repeated at 6, 9, and 12 months.
52 Measurements
were repeated at 6-month intervals over 30-months.
53 All clinical and microbiological procedures
were repeated at 6-month intervals.
54 This correlation
is repeated, at a finer evolutionary scale, within the p
55 The entire procedure
was repeated at a second visit.
56 The protocol
was repeated at age 11-12 and 19 years, and 1516 partici
57 Measures
were repeated at age 7 years.
58 This imaging protocol
was repeated at an interval of 3-4 wk after initiation o
59 The dinucleotides GC, AA (=TT) and TA
are repeated at approximately 10 bp intervals, with the
60 Catheter tips were cultured and venography
was repeated at catheter removal.
61 Complete compression ultrasonography
was repeated at day 28 +/- 2 after surgery by investigat
62 mples, and clinical periodontal measurements
were repeated at day 10, 1 month, and 3 months following
63 at baseline, and lung function measurements
were repeated at follow-up, approximately 11 years later
64 Resting echocardiography and scintigraphy
were repeated at &
gt; or = 6 weeks.
65 Sound exposures
were repeated at intervals to determine the time course
66 surements with time-domain processing should
be repeated at least three times to ensure accuracy and
67 eduction product, and this redox cycle could
be repeated at least three times.
68 Each experiment
was repeated at least three times in triplicate.
69 All experiments
were repeated at least three times.
70 Studies
were repeated at least twice using cells from different
71 Each condition
was repeated at left pulmonary artery/right pulmonary ar
72 Albuterol administration
was repeated at operating frequencies of 5 and 15 Hz, in
73 A second ECHO
was repeated at randomization (45 +/- 25 days later).
74 cancer precursor lesions, and tests need to
be repeated at regular intervals.
75 more rapidly when cyclic voltammetric scans
are repeated at short intervals (4 ms).
76 Angiography
was repeated at six months in 20 patients.
77 erform or interpret, no calibration, and can
be repeated at the bedside to generate almost continuous
78 The cutting and healing can
be repeated at the same location for multiple cycles.
79 Blood sampling
was repeated at the end of each treatment phase (3 weeks
80 of a drive cycle at one stimulation site, it
was repeated at the other.
81 s (except the Structured Clinical Interview)
were repeated at the 2-, 6-, and 12-month follow-up eval
82 ated, blinded examiner and open measurements
were repeated at the 9-month second stage surgery.
83 Final open and closed measures from a stent
were repeated at the 9-month second stage surgery.
84 ents were made just before randomization and
were repeated at the end of 3 months of therapy.
85 Baseline measurements
were repeated at the end of each arm.
86 Studies
were repeated at the end of treatment (3 months) and at
87 p, the assessments done before randomisation
were repeated at the final assessment.
88 Flow rate measurements
were repeated at the four pressure levels.
89 This design
was repeated at two sites that represent different outco
90 Each test
was repeated at two subsequent visits after an initial p
91 BHR
was repeated at week 2 and then weekly until it decrease
92 Liver biopsies
were repeated at week 36.
93 Bronchial allergen provocations (BAP)
were repeated at weeks 1, 2, 4, and 8.